Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации
Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации
Бубнова М.Г., Шляхто Е.В., Аронов Д.М., Белевский А.С., Герасименко М.Ю., Глезер М.Г., Гордеев М.Н., Драпкина О.М., Иванова Г.Е., Иоселиани Д.Г., Карамнова Н.С., Космачева Е.Д., Кулешов А.В., Кукшина А.А., Лядов К.В., Лямина Н.П., Макарова М.Р., Мещерякова Н.Н., Никитюк Д.Б., Пасечник И.Н., Персиянова-Дуброва А.Л., Погонченкова И.В., Свет А.В., Стародубова А.В., Тутельян В.А. Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации. Консенсус экспертов Российского общества кардиосоматической реабилитации и вторичной профилактики (РосОКР), Российского кардиологического общества (РКО), Российского респираторного общества (РРО), Союза реабилитологов России (СРР), Российского союза нутрициологов, диетологов и специалистов пищевой индустрии (РоСНДП), Российского общества профилактики неинфекционных заболеваний (РОПНИЗ). CardioСоматика. 2021; 12 (2): 64–101.
DOI: 10.26442/22217185.2021.2.200840
________________________________________________
Bubnova MG, Shliakhto EV, Aronov DM, Belevskii AS, Gerasimenko MIu, Glezer MG, Gordeev MN, Drapkina OM, Ivanova GE, Ioseliani DG, Karamnova NS, Kosmacheva ED, Kuleshov AV, Kukshina AA, Liadov KV, Liamina NP, Makarova MR, Meshcheriakova NN, Nikitiuk DB, Pasechnik IN, Persiianova-Dubrova AL, Pogonchenkova IV, Svet AV, Starodubova AV, Tutel'ian VA. Novel сoronavirus infectious disease COVID-19: features of comprehensive cardiac and respiratory rehabilitation. Consensus of experts from the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RSCR&SP), the Russian Society of Cardiology (RSC), the Russian Respiratory Society (RRS), the Union of Rehabilitologists of Russia (URR), the Russian Union of Nutritionists, Dieticians and Food Industry Specialists (RUNDF), the Russian Society for Prevention noninfectious diseases (RSPNID).Cardiosomatics. 2021; 12 (2): 64–101. DOI: 10.26442/22217185.2021.2.200840
Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации
Бубнова М.Г., Шляхто Е.В., Аронов Д.М., Белевский А.С., Герасименко М.Ю., Глезер М.Г., Гордеев М.Н., Драпкина О.М., Иванова Г.Е., Иоселиани Д.Г., Карамнова Н.С., Космачева Е.Д., Кулешов А.В., Кукшина А.А., Лядов К.В., Лямина Н.П., Макарова М.Р., Мещерякова Н.Н., Никитюк Д.Б., Пасечник И.Н., Персиянова-Дуброва А.Л., Погонченкова И.В., Свет А.В., Стародубова А.В., Тутельян В.А. Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации. Консенсус экспертов Российского общества кардиосоматической реабилитации и вторичной профилактики (РосОКР), Российского кардиологического общества (РКО), Российского респираторного общества (РРО), Союза реабилитологов России (СРР), Российского союза нутрициологов, диетологов и специалистов пищевой индустрии (РоСНДП), Российского общества профилактики неинфекционных заболеваний (РОПНИЗ). CardioСоматика. 2021; 12 (2): 64–101.
DOI: 10.26442/22217185.2021.2.200840
________________________________________________
Bubnova MG, Shliakhto EV, Aronov DM, Belevskii AS, Gerasimenko MIu, Glezer MG, Gordeev MN, Drapkina OM, Ivanova GE, Ioseliani DG, Karamnova NS, Kosmacheva ED, Kuleshov AV, Kukshina AA, Liadov KV, Liamina NP, Makarova MR, Meshcheriakova NN, Nikitiuk DB, Pasechnik IN, Persiianova-Dubrova AL, Pogonchenkova IV, Svet AV, Starodubova AV, Tutel'ian VA. Novel сoronavirus infectious disease COVID-19: features of comprehensive cardiac and respiratory rehabilitation. Consensus of experts from the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RSCR&SP), the Russian Society of Cardiology (RSC), the Russian Respiratory Society (RRS), the Union of Rehabilitologists of Russia (URR), the Russian Union of Nutritionists, Dieticians and Food Industry Specialists (RUNDF), the Russian Society for Prevention noninfectious diseases (RSPNID).Cardiosomatics. 2021; 12 (2): 64–101. DOI: 10.26442/22217185.2021.2.200840
В соглашении экспертов российских сообществ обсуждаются вопросы комплексной медицинской реабилитации больных новой коронавирусной инфекцией. Коронавирусная болезнь 2019 (COVID-19) – контагиозное инфекционное заболевание, которое может вызывать респираторные, кардиологические, двигательные, метаболические, нейрокогнитивные и психические нарушения, т.е. полиорганную дисфункцию. Больные, выжившие после COVID-19, особенно после тяжелой формы, сталкиваются с серьезными проблемами психологического и физического характера, посттравматическим стрессом, когнитивной дисфункцией, нутритивной недостаточностью и обострением сопутствующих хронических заболеваний. У части пациентов, независимо от тяжести течения коронавирусной инфекции, отмечается продолжительное течение болезни («chronic COVID», «long COVID»). Появились данные о развитии «пост-COVID-19-синдрома». В этой связи больные, перенесшие COVID-19, будут нуждаться в проведении реабилитационных мероприятий. В Консенсусе экспертов российских сообществ представлены общие принципы, этапы и аспекты медицинской реабилитации после COVID-19, показания и противопоказания к реабилитационным вмешательствам. Консенсусный документ включает рекомендации по комплексной кардиологической и респираторной реабилитации, а также особенности реабилитационной помощи при разных вариантах клинического течения COVID-19 в рамках национальной трехэтапной системы медицинской реабилитации.
In the Consensus of experts from Russian societies, issues of comprehensive medical rehabilitation of patients with a new coronavirus infection are being discussed. Coronavirus Disease 2019 (COVID-19) is a contagious infectious disease that can cause respiratory, cardiac, motor, metabolic, neurocognitive and mental disorders, i.e. multiple organ dysfunction. Patients who survived COVID-19, especially after a severe course, face serious psychological and physical problems, post-traumatic stress, cognitive dysfunction, nutritional deficiencies and exacerbation of concomitant chronic diseases. Some patients, regardless of the severity of the coronavirus infection, have a long-term course of disease ("chronic COVID", "long-term COVID"). There is evidence of the development of "post-COVID-19 syndrome". In this regard, patients with COVID-19 need rehabilitation. The Consensus of experts from Russian societies provides general principles, stages and aspects of medical rehabilitation after COVID-19, indications and contraindications for rehabilitation interventions. The Consensus includes recommendations on comprehensive cardiac and respiratory rehabilitation, as well as the features of the rehabilitation of patients with different clinical course of COVID-19 within the framework of the national three-stage medical rehabilitation system.
1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 48. World Health Organization. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.p.... Accessed: 22.03.2021.
2. Brugliera L, Spina A, Castellazzi P, et al. Rehabilitation of COVID-19 patients. J Rehabil Med. 2020;52(4):jrm00046. DOI:10.2340/16501977-2678
3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. DOI:10.1001/jama.2020.1585
4. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г., и др. Международный регистр «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (AКТИВ SARS-CoV-2)»: анализ 1000 пациентов. Рос. кардиол. журн. 2020;25(11):4165 [Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. 2020;25(11):4165 (in Russian)]. DOI:10.15829/1560-4071-2020-4165
5. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. DOI:10.1007/s00134-020-05991-x
6. Глыбочко П.В., Фомин В.В., Авдеев С.Н., и др. Клиническая характеристика 1007 больных тяжелой SARS-CoV-2 пневмонией, нуждавшихся в респираторной поддержке. Клин. фармакол. тер. 2020;29(2):21-9
[Glybochko PV, Fomin VV, Avdeev SN, et al. Clinical characteristics of 1007 intensive care unit patients with SARS-CoV-2 pneumonia. Klinicheskaya farmakologiya i terapiya. 2020;29(2):21-9 (in Russian)]. DOI:10.32756/0869-5490-2020-2-21-29
7. National Institute for Health and Care Excellence, Royal College of General Practitioners, Healthcare Improvement Scotland SIGN. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence, 2020. Available at: www.nice.org.uk/guidance/ng188. Accessed: 18.12.2020.
8. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. DOI:10.1038/s41586-020-2012-7
9. Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90. DOI:10.1007/s00134-020-05985-9
10. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell.
2020;181(2):1-10. DOI:10.1016/j.cell.2020.02.052
11. Самсонова М.В., Черняев А.Л., Омарова Ж.Р., и др. Особенности патологической анатомии легких при COVID-19. Пульмонология. 2020;30(5):519-32 [Samsonova MV, Chernyaev AL, Omarova ZhR, et al. Features of pathological anatomy of lungs at COVID-19. Pul’monologiya. 2020;30(5):519-32 (in Russian)]. DOI:10.18093/0869-0189-2020-30-5-519-532
12. Зайратьянц О.В., Самсонова М.В., Михалева Л.М., и др. Патологическая анатомия легких при COVID-19: атлас. Под ред. О.В. Зайратьянца. М.–Рязань: Рязанская областная типография, 2020 [Zairatyants OV, Samsonova MV, Mikhaleva LM, et al. Pathological anatomy of the lungs by COVID-19: atlas. Edited by O.V. Zairatyants. Moscow–Ryazan: Ryazan regional printing house, 2020 (in Russian)].
13. Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. DOI:10.1016/j.rmed.2020.105941
14. Pericàs JM, Hernandez-Meneses M, Sheahan TP, et al. COVID-19: from epidemiology to treatment. Eur Heart J. 2020;41(22):2092-112.
DOI:10.1093/eurheartj/ehaa462
15. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43. DOI:10.1001/jamaimternmed.2020.0994
16. Parohan M, Yaghoubi S, Seraji A, et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416-24. DOI:10.1080/13685538.2020.1774748
17. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 2020. Available at: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance. Accessed: 20.03.2021.
18. Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821-9. DOI:10.1093/eurheartj/ehaa388
19. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.DOI:10.1016/S0140-6736(20)30566-3
20. Chen R, Liang W, Jiang M, et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020;158(1):97-105. DOI:10.1016/j.chest.2020.04.010
21. Hendren NS, Drazner MH, Bozkurt B, et al. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020;141(23):1903-14.
DOI:10.1161/CIRCULATIONAHA.120.047349
22. Guzik T, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-87. DOI:10.1093/cvr/cvaa106
23. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230-2. DOI:10.1007/s00059-020-04909-z
24. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-98. DOI:10.1007/s00134-020-06062-x
25. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743-6. DOI:10.1111/jth.14869
26. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. DOI:10.1016/j.thromres.2020.04.013
27. Poissy J, Goutay J, Caplan M, et al. Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020;142(2):184-6. DOI:10.1161/CIRCULATIONAHA.120.047430
28. Bansal M. Cardiovascular disease and COVID-19. Diabetes and Metab Syndr. 2020;14(3):247-50. DOI:10.1016/j.dsx.2020.03.013
29. Hendren NS, Grodin JL, Drazner MH. Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019. J Card Fail. 2020;26(6):466-9.
DOI:10.1016/j.cardfail.2020.05.006
30. Cooper Jr LT. Myocarditis. N Engl J Med. 2009;360(15):1526-38.
DOI:10.1056/NEJMra 0800028
31. Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-59. DOI:10.1136/bjsports-2020-102596
32. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. DOI:10.1001/jamaneurol.2020.1127
33. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60. DOI:10.1056/NEJMc2009787
34. Pérez CA. Looking ahead: The risk of neurologic complications due to COVID-19. Neurol Clin Pract. 2020;10(4):371-4.
DOI:10.1212/CPJ.0000000000000836
35. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296(2):E119-E120. DOI:10.1148/radiol.2020201187
36. Toscano G, Palmerini F, Ravaglia S, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6. DOI:10.1056/NEJMc2009191
37. Talan J. COVID-19: Neurologists in Italy to Colleagues in US: Look for Poorly-Defined Neurologic Conditions in Patients with the Coronavirus. Neurology Today, American Academy of Neurology. 2020. Available at: https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=920&fbclid=Iw. Accessed: 20.03.2021.
38. British Geriatrics Society. COVID-19: Dementia and cognitive impairment. Available at: https://www.bgs.org.uk/resources/covid-19-dementia-and-cognitive-impairment. Accessed: 20.03.2021.
39. Zhu S, Gao Q, Yang L, et al. Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China. PLoS ONE. 2020;15(12):e0243883. DOI:10.1371/journal.pone.0243883
40. Xiang YT, Zhao YJ, Liu ZH, et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J Biol Sci. 2020;16(10):1741-4. DOI:10.7150/ijbs.45072
41. Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020;158(6):1518-9. DOI:10.1053/j.gastro.2020.02.054
42. Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-78. DOI:10.1016/S2468-1253(20)30126-6
43. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. DOI:10.1056/NEJMoa2002032
44. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 9 (26.10.2020). Министерство здравоохранения Российской Федерации. Режим доступа: https://www.rosminzdrav.ru/news/2020/26/10/14109-minzdrav-rossii-utverdil-7-versiyumetodicheskih-eko.... Ссылка активна на 20.03.2021 [Temporary guidelines for Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 9 (26.10.2020) of the Ministry of health of the Russian Federation. Available at: https://www.rosminzdrav.ru/news/2020/26/10/14109-minzdrav-rossii-utverdil-7-versiyumetodicheskih-eko.... Accessed: 20.03.2021 (in Russian)].
45. Заболотских И.Б., Киров М.Ю., Лебединский К.М., и др. Анестезиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID-19. Методические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов». Вестник интенсивной терапии им. А.И. Салтанова. 2020;S1:9-120 [Zabolotskikh IB, Kirov MYu, Lebedinskii KM, et al. Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines. Annals of Critical Care. 2020;S1:9-120 (in Russian)].DOI:10.21320/1818-474X-2020-S1-9-120
46. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. DOI:10.1016/S2213-2600(20)30076-X
47. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. DOI:10.1016/S2213-2600(20)30079-5
48. Vitacca M, Carone M, Clini EM, et al. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper. Respiration. 2020;99(6):493-9. DOI:10.1159/000508399
49. Thomas P, Baldwin C, Bissett B, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73-82. DOI:10.1016/j.jphys.2020.03.011
50. Ohtake PJ, Lee AC, Scott JC, et al. Physical Impairments Associated With Post-Intensive Care Syndrome: Systematic Review Based on the World Health Organization’s International Classification of Functioning, Disability and Health Framework. Phys Ther. 2018;98(8):631-45. DOI:10.1093/ptj/pzy059
51. Белкин А.А., Авдюнина И.А., Варако Н.А., и др. Реабилитация в интенсивной терапии. Клинические рекомендации. Вестник восстановительной медицины. 2017;2(78):139-43 [Belkin AA, Avdiunina IA, Varako NA, et al. Reabilitatsiia v intensivnoi terapii. Klinicheskie rekomendatsii. Vestnik vosstanovitel’noi meditsiny. 2017;2(78):139-43 (in Russian)].
52. Herridge MS, Moss M, Hough CL, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 2016;42(5):725-38. DOI:10.1007/s00134-016-4321-8
53. Carda S, Invernizzi M, Bavikatte G, et al. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Ann Phys Rehabil Med. 2020;63(6):554-6. DOI:10.1016/j.rehab.2020.04.001
54. National Institute for Health and Care Excellence. NICE & SIGN announce latest rapid Covid-19 guideline will address long Covid. Oct 5, 2020. Available at: https://www.nice.org.uk/news/article/nice-sign-announce-latest-rapid-covid-19-guideline-will-address... Accessed: 10.12.2020.
55. Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324(6):603-5. DOI:10.1001/jama.2020.12603
56. Perrin R, Riste L, Hann M, et al. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. DOI:10.1016/j.mehy.2020.110055
57. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. Available at: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflong-covidsymptoms andcovid19complications. Accessed: 16.12.2020.
58. Vaes AW, Machado FVC, Meys R, et al. Care Dependency in Non-Hospitalized Patients with COVID-19. J Clin Med. 2020;9(9):2946. DOI:10.3390/jcm9092946
59. Временные методические рекомендации. Медицинская реабилитация при новой коронавирусной инфекции (COVID-19). Версия 2 (31.07.2020). Министерство здравоохранения Российской Федерации. Режим доступа: https://xn--80aesfpebagmfblc0a.xn--p1ai/ai/doc/461/attach/28052020_Preg_COVID-19_v1.pdf. Ссылка активна на 20.03.2021 [Temporary guidelines for medical rehabilitation for new coronavirus infection (COVID-19). Version 2 (31.07.2020) of the Ministry of health of the Russian Federation. Available at: https://xn--80aesfpebagmfblc0a.xn--p1ai/ai/doc/461/attach/28052020_Preg_COVID-19_v1.pdf. Accessed: 20.03.2021 (in Russian)].
60. Simpson R, Robinson L. Rehabilitation After Critical Illness in People With COVID-19 Infection. Am J Phys Med Rehabil. 2020;99(6):470-4.
DOI:10.1097/PHM.0000000000001443
61. Tingbo L, Hongliu C, Yu C, et al. Handbook of COVID-19. Prevention and Treatment. 2020. Available at: http://education.almazovcentre.ru/wp-content/uploads/2020/03/Spravochnik_po_profilaktike_i_lecheniju.... Accessed: 20.03.2021.
62. Zhao HM, Xie YX, Wang C. Chinese Association of Rehabilitation Medicine, Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine Rehabilitation. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl). 2020;133(13):1595-602. DOI:10.1097/CM9.0000000000000848
63. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-44. DOI: 10.1164/rccm.2107138
64. Centers for Disease Control and Prevention. Ending Home Isolation for Persons with COVID-19 Not in Healthcare Settings (Interim Guidance). 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html. Accessed: 20.03.2021.
65. Cheng YY, Chen CM, Huang WC, et al. Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation. J Formos Med Assoc. 2021;120(1):83-92. DOI:10.1016/j.jfma.2020.08.015
66. Yang LL, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis Transl Med. 2020;6(2):79-86. DOI:10.1016/j.cdtm.2020.05.002
67. Авдеев С.Н., Царева Н.А., Мержоева З.М., и др. Практические рекомендации по кислородотерапии и респираторной поддержке пациентов с COVID-19 на дореанимационном этапе. Пульмонология. 2020;30(2):151-63 [Avdeev SN, Tsareva NA, Merzhoeva ZM, et al. Practical guidelines for oxygen therapy and respiratory support for patients with COVID-19 in the pre-life support. Pul’monologiya. 2020;30(2):151-63
(in Russian)]. DOI:10.18093/0869-0189-2020-30-2-151-163
68. Liang T. Handbook of COVID-19. Prevention and Treatment. The First Affiliated Hospital, Zhejiang University School of Medicine. 2020;1-60. Available at: https://esge.org/documents/Handbook_of_COVID-19._Prevention_and_Treatment.pdf. Accessed: 20.03.2021
69. Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19. Phys Ther. 2020;100(9):1444-57. DOI:10.1093/ptj/pzaa114
70. Мещерякова Н.Н., Белевский А.С., Кулешов А.В. Легочная реабилитация пациентов, перенесших коронавирусную инфекцию COVID-19 (клинические примеры). Пульмонология. 2020;30(5):715-22 [Meshcheryakova NN, Belevsky AS, Kuleshov AV. Pulmonary rehabilitation of patients with coronavirus infection COVID-19, clinical examples. Pul’monologiya. 2020;30(5):715-22 (in Russian)]. DOI:10.18093/0869-0189-2020-30-5-715-722
71. Edwards AM, Wells C, Butterly R. Concurrent inspiratory muscle and cardiovascular training differentially improves both perceptions of effort and 5000 m running performance compared with cardiovascular training alone. Br J Sports Med. 2008;42(10):823-7.
DOI:10.1136/bjsm.2007.045377
72. Enright SJ, Unnithan VB, Heward C, et al. Effect of high-intensity inspiratory muscle training on lung volumes, diaphragm thickness, and exercise capacity in subjects who are healthy. Phys Ther. 2006;86(3):345-54.DOI:10.2522/ptj.2007.87.2.224
73. Geddes EL, O’Brien K, Reid WD, et al. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med. 2008;102(12): 1715-29. DOI:10.1016/j.rmed.2008.07.005
74. Gosselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011;37(2):416-25. DOI:10.1183/09031936.00031810
75. Severin R, Arena R, Lavie CJ, et al. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation. Am J Med. 2020;133(9):1025-32. DOI:10.1016/j.amjmed.2020.04.003
76. Zhou L, Liu HG. Early detection and disease assessment of patients with novel coronavirus pneumonia. Chinese J tuberculosis and respiratory disease. 2020;43(3):167-70. DOI:10.3760/cma.j.issn.1001-0939.2020.0003
77. Bissett B, Gosselink R, van Haren FMP. Respiratory Muscle Rehabilitation in Patients with Prolonged Mechanical Ventilation: A Targeted Approach. Crit Care. 2020;24(1):103. DOI:10.1186/s13054-020-2783-0
78. KNGF position statement. Recommendations for physiotherapy in patients with COVID-19. Amersfoort, Netherlands: Royal Dutch Society for Physiotherapy (KNGF), 2020. Available at: https://www.kngf2.nl/binaries/content/assets/kennisplatform/onbeveiligd/guidelines/recommendations-f.... Accessed: 20.03.2021.
79. Макарова М.Р., Лямина Н.П., Сомов Д.А., и др. Физическая реабилитация при пневмонии, ассоциированной с COVID-19. Учебно-методическое пособие. Москва, 2020 [Makarova MR, Lyamina NP, Somov DA, et al. Physical rehabilitation for СOVID-19 associated pneumonia. Teaching guide. Moscow, 2020 (in Russian)].
80. Attaway A, Hatipoğlu U. Management of patients with COPD during the COVID-19 pandemic. Cleve Clin J Med. 2020. DOI:10.3949/ccjm.87a.ccc007
81. Бубнова М.Г., Персиянова-Дуброва А.Л., Лямина Н.П., Аронов Д.М. Реабилитация после новой коронавирусной инфекции (COVID-19): принципы и подходы. CardioСоматика. 2020;11(4):6-14 [Bubnova MG, Persiyanova-Dubrova AL, Lyamina NP, Aronov DM. Rehabilitation after New Coronavirus Infection (COVID-19): principles and approaches. Cardiosomatics. 2020;11(4):6-14 (in Russian)].
DOI:10.26442/22217185.2020.4.200570
82. Иванова Г.Е., Шмонин А.А., Мальцева М.Н., и др. Реабилитационная помощь в период эпидемии новой коронавирусной инфекции COVID-19 на первом, втором и третьем этапах медицинской реабилитации. Физическая и реабилитационная медицина, медицинская реабилитация. 2020;2(2):98-117 [Ivanova GE, Shmonin AA, Maltseva MN, et al. Rehabilitation Care During the New COVID-19 Coronavirus Infection Epidemic at First, Second and Third Medical Rehabilitation Phases. Physical and rehabilitation medicine, medical rehabilitation. 2020;2(2):98-117 (in Russian)]. DOI:10.36425/rehab34148
83. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59. DOI:10.1249/MSS.0b013e318213fefb
84. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020;2047487320913379. DOI:10.1177/2047487320913379
85. Spruit MA, Singh SJ, Garvey C, et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64. DOI:10.1164/rccm.201309-1634ST
86. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17-96. DOI:10.1093/eurheartj/ehaa605
87. Jones CJ, Rikli RE. Measuring functional fitness of older adults. J Active Aging. 2002;March-April:24-30.
88. Briand J, Behal H, Chenivesse C, et al. The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease. Ther Adv Respir Dis. 2018;12:1-10. DOI:10.1177/1753466618793028
89. Bohannon RW, Wang YC, Gershon RC. Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness. Arch Phys Med Rehabil. 2015;96(3):472-7. DOI:10.1016/j.apmr.2014.10.006
90. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-46. DOI:10.1183/09031936.00150314
91. Haas F, Sweeney G, Pierre A, et al. Validation of a 2 Minute Step Test for Assessing Functional Improvement. Open J Ther Rehabil. 2017;5(2):71-81. DOI:10.4236/ojtr.2017.52007
92. Coquart JB, Lemaître F, Castres I, et al. Reproducibility and Sensitivity of the 6-Minute Stepper Test in Patients with COPD. COPD. 2015;12(5):533-8. DOI:10.3109/15412555.2014.974733
93. Бубнова М.Г., Аронов Д.М. Обеспечение физической активности граждан, имеющих ограничения в состоянии здоровья. Методические рекомендации. Под ред. С.А. Бойцова. CardioСоматика. 2016;7(1):5-50 [Bubnova MG, Aronov DM. Maintaining physical activity of those with limitations in health. Methodic recommendations. Edited by S.A. Boytsov. Cardiosomatics. 2016;7(1):5-50 (in Russian)]
94. Аронов Д.М., Бубнова М.Г., Барбараш О.Л., и др. Национальные российские рекомендации по острому инфаркту миокарда с подъемом сегмента ST электрокардиограммы: реабилитация и вторичная профилактика. Рос. кардиол. журн. 2015;20(1):6-52 [Aronov DM, Bubnova MG, Barbarash OL, et al. Acute ST elevation myocardial infarction: rehabilitation and secondary prevention. National Russian Guidelines. Russian Journal of Cardiology. 2015;20(1):6-52 (in Russian)]. DOI:10.15829/1560‑4071‑2015‑1‑6‑52
95. Бокерия Л.А., Аронов Д.М., Бубнова М.Г., и др. Российские клинические рекомендации. Коронарное шунтирование больных ишемической болезнью сердца: реабилитация и вторичная профилактика. CardioСоматика. 2016;7(3-4):5-71 [Bokeriya LA, Aronov DM, Bubnova MG, et al. Russian clinical guidelines Coronary artery bypass grafting in patients with ischemic heart disease: rehabilitation and secondary prevention. Cardiosomatics. 2016;7(3-4):5-71 (in Russian)]
96. Bartlo P, Bauer N. Pulmonary Rehabilitation Post-Acute Care for Covid-19. Available at: https://youtu.be/XjY_7O3Qpd8. Accessed: 20.03.2021.
97. Martorella G, Fredericks S, Sanders J, Wynne R. Breaking pandemic chain reactions: telehealth psychosocial support in cardiovascular disease during COVID-19. Eur J of Cardiovasc Nurs. 2021;20:1-2. DOI:10.1093/eurjcn/zvaa011
98. Barazzoni R, Bischoff SC, Breda J, et al. Endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631-8. DOI:10.1016/j.clnu.2020.03.022
99. Гречко А.В., Евдокимов Е.А., Котенко О.Н., и др. Нутритивная поддержка пациентов с коронавирусной инфекцией COVID-19. Клиническое питание и метаболизм. 2020;1(2):56-91 [Grechko AV, Evdokimov EA, Kotenko ON, et al. Nutritional Support for Patients with COVID-19 Coronavirus Infection. Clinical nutrition and metabolism. 2020;1(2):56-91 (in Russian)]. DOI:10.36425/clinnutrit42278
100. Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus: The species and its viruses, a statement of the Coronavirus Study Group. 2020. Available at: https://www.researchgate.net/publication/339441746_Severe_acute_respiratory_syndrome-related_coronav.... Accessed: 20.03.2021.
101. Martindale R, Patel JJ, Taylor B, et al. Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care. Available at: https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/COVID19/Nutr.... Accessed: 01.04.2020.
102. Пасечник И.Н. Нутритивная поддержка больных коронавирусной инфекцией в критических состояниях. Анестезиология и реаниматология. 2020;3:70-5 [Pasechnik IN. Nutritional Support for Critically Ill Patients with coronavirus infection. Russian Journal of Anaesthesiology and Reanimatology. 2020;3:70-5 (In Russian)].
DOI:10.17116/anaesthesiology202003170
103. Critical Care Specialist Group (CCSG) of the BDA Guidance on management of nutrition and dietetic services during the COVID-19 pandemic. Version 1.4 - 31/03/2020. Available at: https://www.bda.uk.com/uploads/assets/f5215258-7a34-4426-83620ba89f87c638/63decf82-db85-41d7-b5a6cba.... Accessed: 01.04.2020.
104. Приказ Минздрава России от 05.08.2003 N330 (с поправками от 24.11.2016) «О мерах по совершенствованию лечебного питания в лечебно-профилактических учреждениях Российской Федерации». Приказ Минздрава России от 05.05.2016 N279н «Об утверждении порядка организации санаторно-курортного лечения». Режим доступа: https://www.base.garant.ru. Ссылка активна на 01.04.2020 [Order of the Ministry of Health of the Russian Federation from 05.08.2003 N330 (as amended on 24.11.2016) “On measures to improve medical nutrition in medical institutions of the Russian Federation”. Order of the Ministry of Health of the Russian Federation from 05.05.2016 N279n “On the approval of the order of the organization of spa treatment”. Available at: https://www.base.garant.ru. Accessed: 01.04.2020 (in Russian)].
105. Wang TJ, Chau B, Lui M, et al. Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769-74. DOI:10.1097/PHM.0000000000001505
________________________________________________
1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 48. World Health Organization. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.p.... Accessed: 22.03.2021.
2. Brugliera L, Spina A, Castellazzi P, et al. Rehabilitation of COVID-19 patients. J Rehabil Med. 2020;52(4):jrm00046. DOI:10.2340/16501977-2678
3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. DOI:10.1001/jama.2020.1585
4. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. 2020;25(11):4165 (in Russian). DOI:10.15829/1560-4071-2020-4165
5. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. DOI:10.1007/s00134-020-05991-x
6. Glybochko PV, Fomin VV, Avdeev SN, et al. Clinical characteristics of 1007 intensive care unit patients with SARS-CoV-2 pneumonia. Klinicheskaya farmakologiya i terapiya. 2020;29(2):21-9 (in Russian) DOI:10.32756/0869-5490-2020-2-21-29
7. National Institute for Health and Care Excellence, Royal College of General Practitioners, Healthcare Improvement Scotland SIGN. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence, 2020. Available at: www.nice.org.uk/guidance/ng188. Accessed: 18.12.2020.
8. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. DOI:10.1038/s41586-020-2012-7
9. Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90. DOI:10.1007/s00134-020-05985-9
10. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):1-10. DOI:10.1016/j.cell.2020.02.052
11. Samsonova MV, Chernyaev AL, Omarova ZhR, et al. Features of pathological anatomy of lungs at COVID-19. Pul’monologiya. 2020;30(5):519-32 (in Russian)
DOI:10.18093/0869-0189-2020-30-5-519-532
12. Zairatyants OV, Samsonova MV, Mikhaleva LM, et al. Pathological anatomy of the lungs by COVID-19: atlas. Edited by O.V. Zairatyants. Moscow–Ryazan: Ryazan regional printing house, 2020 (in Russian)
13. Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. DOI:10.1016/j.rmed.2020.105941
14. Pericàs JM, Hernandez-Meneses M, Sheahan TP, et al. COVID-19: from epidemiology to treatment. Eur Heart J. 2020;41(22):2092-112.
DOI:10.1093/eurheartj/ehaa462
15. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43. DOI:10.1001/jamaimternmed.2020.0994
16. Parohan M, Yaghoubi S, Seraji A, et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416-24. DOI:10.1080/13685538.2020.1774748
17. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 2020. Available at: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance. Accessed: 20.03.2021.
18. Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821-9. DOI:10.1093/eurheartj/ehaa388
19. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.DOI:10.1016/S0140-6736(20)30566-3
20. Chen R, Liang W, Jiang M, et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020;158(1):97-105. DOI:10.1016/j.chest.2020.04.010
21. Hendren NS, Drazner MH, Bozkurt B, et al. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020;141(23):1903-14.
DOI:10.1161/CIRCULATIONAHA.120.047349
22. Guzik T, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-87. DOI:10.1093/cvr/cvaa106
23. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230-2. DOI:10.1007/s00059-020-04909-z
24. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-98. DOI:10.1007/s00134-020-06062-x
25. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743-6. DOI:10.1111/jth.14869
26. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. DOI:10.1016/j.thromres.2020.04.013
27. Poissy J, Goutay J, Caplan M, et al. Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020;142(2):184-6. DOI:10.1161/CIRCULATIONAHA.120.047430
28. Bansal M. Cardiovascular disease and COVID-19. Diabetes and Metab Syndr. 2020;14(3):247-50. DOI:10.1016/j.dsx.2020.03.013
29. Hendren NS, Grodin JL, Drazner MH. Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019. J Card Fail. 2020;26(6):466-9. DOI:10.1016/j.cardfail.2020.05.006
30. Cooper Jr LT. Myocarditis. N Engl J Med. 2009;360(15):1526-38.
DOI:10.1056/NEJMra 0800028
31. Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-59. DOI:10.1136/bjsports-2020-102596
32. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. DOI:10.1001/jamaneurol.2020.1127
33. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60. DOI:10.1056/NEJMc2009787
34. Pérez CA. Looking ahead: The risk of neurologic complications due to COVID-19. Neurol Clin Pract. 2020;10(4):371-4. DOI:10.1212/CPJ.0000000000000836
35. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296(2):E119-E120. DOI:10.1148/radiol.2020201187
36. Toscano G, Palmerini F, Ravaglia S, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6. DOI:10.1056/NEJMc2009191
37. Talan J. COVID-19: Neurologists in Italy to Colleagues in US: Look for Poorly-Defined Neurologic Conditions in Patients with the Coronavirus. Neurology Today, American Academy of Neurology. 2020. Available at: https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=920&fbclid=Iw. Accessed: 20.03.2021.
38. British Geriatrics Society. COVID-19: Dementia and cognitive impairment. Available at: https://www.bgs.org.uk/resources/covid-19-dementia-and-cognitive-impairment. Accessed: 20.03.2021.
39. Zhu S, Gao Q, Yang L, et al. Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China. PLoS ONE. 2020;15(12):e0243883. DOI:10.1371/journal.pone.0243883
40. Xiang YT, Zhao YJ, Liu ZH, et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J Biol Sci. 2020;16(10):1741-4. DOI:10.7150/ijbs.45072
41. Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020;158(6):1518-9. DOI:10.1053/j.gastro.2020.02.054
42. Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-78. DOI:10.1016/S2468-1253(20)30126-6
43. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
DOI:10.1056/NEJMoa2002032
44. Temporary guidelines for Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 9 (26.10.2020) of the Ministry of health of the Russian Federation. Available at: https://www.rosminzdrav.ru/news/2020/26/10/14109-minzdrav-rossii-utverdil-7-versiyumetodicheskih-eko.... Accessed: 20.03.2021 (in Russian)
45. Zabolotskikh IB, Kirov MYu, Lebedinskii KM, et al. Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines. Annals of Critical Care. 2020;S1:9-120 (in Russian)
DOI:10.21320/1818-474X-2020-S1-9-120
46. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. DOI:10.1016/S2213-2600(20)30076-X
47. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. DOI:10.1016/S2213-2600(20)30079-5
48. Vitacca M, Carone M, Clini EM, et al. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper. Respiration. 2020;99(6):493-9. DOI:10.1159/000508399
49. Thomas P, Baldwin C, Bissett B, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73
82. DOI:10.1016/j.jphys.2020.03.011
50. Ohtake PJ, Lee AC, Scott JC, et al. Physical Impairments Associated With Post-Intensive Care Syndrome: Systematic Review Based on the World Health Organization’s International Classification of Functioning, Disability and Health Framework. Phys Ther. 2018;98(8):631-45. DOI:10.1093/ptj/pzy059
51. Belkin AA, Avdiunina IA, Varako NA, et al. Reabilitatsiia v intensivnoi terapii. Klinicheskie rekomendatsii. Vestnik vosstanovitel’noi meditsiny. 2017;2(78):139-43 (in Russian)
52. Herridge MS, Moss M, Hough CL, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 2016;42(5):725-38.
DOI:10.1007/s00134-016-4321-8
53. Carda S, Invernizzi M, Bavikatte G, et al. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Ann Phys Rehabil Med. 2020;63(6):554-6. DOI:10.1016/j.rehab.2020.04.001
54. National Institute for Health and Care Excellence. NICE & SIGN announce latest rapid Covid-19 guideline will address long Covid. Oct 5, 2020. Available at: https://www.nice.org.uk/news/article/nice-sign-announce-latest-rapid-covid-19-guideline-will-address... Accessed: 10.12.2020.
55. Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324(6):603-5. DOI:10.1001/jama.2020.12603
56. Perrin R, Riste L, Hann M, et al. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. DOI:10.1016/j.mehy.2020.110055
57. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. Available at: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflong-covidsymptoms andcovid19complications. Accessed: 16.12.2020.
58. Vaes AW, Machado FVC, Meys R, et al. Care Dependency in Non-Hospitalized Patients with COVID-19. J Clin Med. 2020;9(9):2946. DOI:10.3390/jcm9092946
59. Temporary guidelines for medical rehabilitation for new coronavirus infection (COVID-19). Version 2 (31.07.2020) of the Ministry of health of the Russian
Federation. Available at: https://xn--80aesfpebagmfblc0a.xn--p1ai/ai/doc/461/attach/28052020_Preg_COVID-19_v1.pdf. Accessed: 20.03.2021 (in Russian)
60. Simpson R, Robinson L. Rehabilitation After Critical Illness in People With COVID-19 Infection. Am J Phys Med Rehabil. 2020;99(6):470-4.
DOI:10.1097/PHM.0000000000001443
61. Tingbo L, Hongliu C, Yu C, et al. Handbook of COVID-19. Prevention and Treatment. 2020. Available at: http://education.almazovcentre.ru/wp-content/uploads/2020/03/Spravochnik_po_profilaktike_i_lecheniju.... Accessed: 20.03.2021.
62. Zhao HM, Xie YX, Wang C. Chinese Association of Rehabilitation Medicine, Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine Rehabilitation. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl). 2020;133(13):1595-602. DOI:10.1097/CM9.0000000000000848
63. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-44. DOI: 10.1164/rccm.2107138
64. Centers for Disease Control and Prevention. Ending Home Isolation for Persons with COVID-19 Not in Healthcare Settings (Interim Guidance). 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html. Accessed: 20.03.2021.
65. Cheng YY, Chen CM, Huang WC, et al. Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation.
J Formos Med Assoc. 2021;120(1):83-92. DOI:10.1016/j.jfma.2020.08.015
66. Yang LL, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis Transl Med. 2020;6(2):79-86. DOI:10.1016/j.cdtm.2020.05.002
67. Авдеев С.Н., Царева Н.А., Мержоева З.М., и др. Практические рекомендации по кислородотерапии и респираторной поддержке пациентов с COVID-19 на дореанимационном этапе. Пульмонология. 2020;30(2):151-63 [Avdeev SN, Tsareva NA, Merzhoeva ZM, et al. Practical guidelines for oxygen therapy and respiratory support for patients with COVID-19 in the pre-life support. Pul’monologiya. 2020;30(2):151-63
(in Russian)]. DOI:10.18093/0869-0189-2020-30-2-151-163
68. Liang T. Handbook of COVID-19. Prevention and Treatment. The First Affiliated Hospital, Zhejiang University School of Medicine. 2020;1-60. Available at: https://esge.org/documents/Handbook_of_COVID-19._Prevention_and_Treatment.pdf. Accessed: 20.03.2021
69. Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19. Phys Ther. 2020;100(9):1444-57. DOI:10.1093/ptj/pzaa114
70. Meshcheryakova NN, Belevsky AS, Kuleshov AV. Pulmonary rehabilitation of patients with coronavirus infection COVID-19, clinical examples. Pul’monologiya. 2020;30(5):715-22 (in Russian) DOI:10.18093/0869-0189-2020-30-5-715-722
71. Edwards AM, Wells C, Butterly R. Concurrent inspiratory muscle and cardiovascular training differentially improves both perceptions of effort and 5000 m running performance compared with cardiovascular training alone. Br J Sports Med. 2008;42(10):823-7.
DOI:10.1136/bjsm.2007.045377
72. Enright SJ, Unnithan VB, Heward C, et al. Effect of high-intensity inspiratory muscle training on lung volumes, diaphragm thickness, and exercise capacity in subjects who are healthy. Phys Ther. 2006;86(3):345-54.DOI:10.2522/ptj.2007.87.2.224
73. Geddes EL, O’Brien K, Reid WD, et al. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med. 2008;102(12): 1715-29. DOI:10.1016/j.rmed.2008.07.005
74. Gosselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011;37(2):416-25. DOI:10.1183/09031936.00031810
75. Severin R, Arena R, Lavie CJ, et al. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19:
A Highly Pressurized Situation. Am J Med. 2020;133(9):1025-32. DOI:10.1016/j.amjmed.2020.04.003
76. Zhou L, Liu HG. Early detection and disease assessment of patients with novel coronavirus pneumonia. Chinese J tuberculosis and respiratory disease. 2020;43(3):167-70. DOI:10.3760/cma.j.issn.1001-0939.2020.0003
77. Bissett B, Gosselink R, van Haren FMP. Respiratory Muscle Rehabilitation in Patients with Prolonged Mechanical Ventilation: A Targeted Approach. Crit Care. 2020;24(1):103. DOI:10.1186/s13054-020-2783-0
78. KNGF position statement. Recommendations for physiotherapy in patients with COVID-19. Amersfoort, Netherlands: Royal Dutch Society for Physiotherapy (KNGF), 2020. Available at: https://www.kngf2.nl/binaries/content/assets/kennisplatform/onbeveiligd/guidelines/recommendations-f.... Accessed: 20.03.2021.
79. Makarova MR, Lyamina NP, Somov DA, et al. Physical rehabilitation for СOVID-19 associated pneumonia. Teaching guide. Moscow, 2020 (in Russian)
80. Attaway A, Hatipoğlu U. Management of patients with COPD during the COVID-19 pandemic. Cleve Clin J Med. 2020. DOI:10.3949/ccjm.87a.ccc007
81. Bubnova MG, Persiyanova-Dubrova AL, Lyamina NP, Aronov DM. Rehabilitation after New Coronavirus Infection (COVID-19): principles and approaches. Cardiosomatics. 2020;11(4):6-14 (in Russian) DOI:10.26442/22217185.2020.4.200570
82. Ivanova GE, Shmonin AA, Maltseva MN, et al. Rehabilitation Care During the New COVID-19 Coronavirus Infection Epidemic at First, Second and Third Medical Rehabilitation Phases. Physical and rehabilitation medicine, medical rehabilitation. 2020;2(2):98-117 (in Russian) DOI:10.36425/rehab34148
83. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59. DOI:10.1249/MSS.0b013e318213fefb
84. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020;2047487320913379. DOI:10.1177/2047487320913379
85. Spruit MA, Singh SJ, Garvey C, et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64. DOI:10.1164/rccm.201309-1634ST
86. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17-96. DOI:10.1093/eurheartj/ehaa605
87. Jones CJ, Rikli RE. Measuring functional fitness of older adults. J Active Aging. 2002;March-April:24-30.
88. Briand J, Behal H, Chenivesse C, et al. The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease. Ther Adv Respir Dis. 2018;12:1-10. DOI:10.1177/1753466618793028
89. Bohannon RW, Wang YC, Gershon RC. Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness. Arch Phys Med Rehabil. 2015;96(3):472-7. DOI:10.1016/j.apmr.2014.10.006
90. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-46. DOI:10.1183/09031936.00150314
91. Haas F, Sweeney G, Pierre A, et al. Validation of a 2 Minute Step Test for Assessing Functional Improvement. Open J Ther Rehabil. 2017;5(2):71-81. DOI:10.4236/ojtr.2017.52007
92. Coquart JB, Lemaître F, Castres I, et al. Reproducibility and Sensitivity of the 6-Minute Stepper Test in Patients with COPD. COPD. 2015;12(5):533-8. DOI:10.3109/15412555.2014.974733
93. Bubnova MG, Aronov DM. Maintaining physical activity of those with limitations in health. Methodic recommendations. Edited by S.A. Boytsov. Cardiosomatics. 2016;7(1):5-50 (in Russian)
94. Aronov DM, Bubnova MG, Barbarash OL, et al. Acute ST elevation myocardial infarction: rehabilitation and secondary prevention. National Russian Guidelines. Russian Journal of Cardiology. 2015;20(1):6-52 (in Russian).
DOI:10.15829/1560‑4071‑2015‑1‑6‑52
95. Bokeriya LA, Aronov DM, Bubnova MG, et al. Russian clinical guidelines Coronary artery bypass grafting in patients with ischemic heart disease: rehabilitation and secondary prevention. Cardiosomatics. 2016;7(3-4):5-71 (in Russian)
96. Bartlo P, Bauer N. Pulmonary Rehabilitation Post-Acute Care for Covid-19. Available at: https://youtu.be/XjY_7O3Qpd8. Accessed: 20.03.2021.
97. Martorella G, Fredericks S, Sanders J, Wynne R. Breaking pandemic chain reactions: telehealth psychosocial support in cardiovascular disease during COVID-19. Eur J of Cardiovasc Nurs. 2021;20:1-2. DOI:10.1093/eurjcn/zvaa011
98. Barazzoni R, Bischoff SC, Breda J, et al. Endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631-8. DOI:10.1016/j.clnu.2020.03.022
99. Grechko AV, Evdokimov EA, Kotenko ON, et al. Nutritional Support for Patients with COVID-19 Coronavirus Infection. Clinical nutrition and metabolism. 2020;1(2):56-91 (in Russian) DOI:10.36425/clinnutrit42278
100. Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus: The species and its viruses, a statement of the Coronavirus Study Group. 2020. Available at: https://www.researchgate.net/publication/339441746_Severe_acute_respiratory_syndrome-related_coronav.... Accessed: 20.03.2021.
101. Martindale R, Patel JJ, Taylor B, et al. Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care. Available at: https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/COVID19/Nutr.... Accessed: 01.04.2020.
102. Pasechnik IN. Nutritional Support for Critically Ill Patients with coronavirus infection. Russian Journal of Anaesthesiology and Reanimatology. 2020;3:70-5 (In Russian)
DOI:10.17116/anaesthesiology202003170
103. Critical Care Specialist Group (CCSG) of the BDA Guidance on management of nutrition and dietetic services during the COVID-19 pandemic. Version 1.4 - 31/03/2020. Available at: https://www.bda.uk.com/uploads/assets/f5215258-7a34-4426-83620ba89f87c638/63decf82-db85-41d7-b5a6cba.... Accessed: 01.04.2020.
104. Order of the Ministry of Health of the Russian Federation from 05.08.2003 N330 (as amended on 24.11.2016) “On measures to improve medical nutrition in medical institutions of the Russian Federation”. Order of the Ministry of Health of the Russian Federation from 05.05.2016 N279n “On the approval of the order of the organization of spa treatment”. Available at: https://www.base.garant.ru. Accessed: 01.04.2020
(in Russian)
105. Wang TJ, Chau B, Lui M, et al. Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769-74. DOI:10.1097/PHM.0000000000001505
1 ФГБОУ «Национальный медицинский исследовательский центр терапии и профилактической медицины» Минздрава России, Москва, Россия;
2 ФГБУ «Национальный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России, Санкт-Петербург, Россия;
3 ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, Москва, Россия;
4 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия;
5 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
6 ЧОУ ДПО «Институт Милтона Эриксона», Москва, Россия;
7 ФГБУ «Федеральный центр мозга и нейротехнологий» Федерального медико-биологического агентства, Москва, Россия;
8 ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава России, Краснодар, Россия;
9 ГБУЗ «Научно-исследовательский институт – Краевая клиническая больница №1 им. профессора С.В. Очаповского» Минздрава Краснодарского края, Краснодар, Россия;
10 Клиника респираторной медицины «ИнтеграМед», Москва, Россия;
11 ГАУЗ «Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медицины» Департамента здравоохранения г. Москвы, Москва, Россия;
12 Многопрофильный медицинский центр «Клиники Лядова», Химки, Россия;
13 ФГБУН «Федеральный исследовательский центр питания, биотехнологии и безопасности пищи», Москва, Россия;
14 ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента РФ, Москва, Россия;
15 ГБУЗ г. Москвы «Городская клиническая больница №1 им. Н.И. Пирогова» Департамента здравоохранения г. Москвы, Москва, Россия
*mbubnova@gnicpm.ru
________________________________________________
Marina G. Bubnova*1, Evgenii V. Shliakhto2, David M. Aronov1, Andrei S. Belevskii3, Marina Iu. Gerasimenko4, Mariia G. Glezer5, Mikhail N. Gordeev6,7, Oksana M. Drapkina1, Galina E. Ivanova3,7, David G. Ioseliani5, Natalia S. Karamnova1, Elena D. Kosmacheva8,9, Andrei V. Kuleshov10, Anastasiia A. Kukshina11, Konstantin V. Liadov5,12, Nadezhda P. Liamina11, Marina R. Makarova11, Natalia N.Meshcheriakova3, Dmitrii B. Nikitiuk13, Igor N. Pasechnik14, Anna L. Persiianova-Dubrova1, Irena V. Pogonchenkova11, Aleksei V. Svet15, Antonina V. Starodubova13, Viktor A. Tutel'ian13
1 National Research Center for Therapy and Preventive Medicine, Moscow, Russia;
2 Almazov National Medical Research Centre, Saint Petersburg, Russia;
3 Pirogov Russian National Research Medical University, Moscow, Russia;
4 Russian Medical Academy of Continuous Professional Education, Moscow, Russia;
5 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
6 Milton Erickson Institute, Moscow, Russia;
7 Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia;
8 Kuban State Medical University, Krasnodar, Russia;
9 Scientific Research Institute – Ochapovsky Regional Clinical Hospital №1, Krasnodar, Russia;
10 Respiratory Medicine Clinic “IntegraMed”, Moscow, Russia;
11 Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine, Moscow, Russia;
12 Multidisciplinary Medical Center “Lyadov Clinics”, Khimki, Russia;
13 Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russia;
14 Central State Medical Academy of the President of the Russian Federation, Moscow, Russia;
15 Pirogov City Clinical Hospital №1, Moscow, Russia
*mbubnova@gnicpm.ru